Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Ballester · SciRah

Researcher profile · Semantic Scholar

O. Ballester

Share profile

O. Ballester — researcher profile on SciRah

h-index: 15
Works: 52
Citations: 2,669

Most-cited papers

Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.
J. Berenson, A. Lichtenstein, L. Porter, M. Dimopoulos +13 more
1996New England Journal of Medicine1,077 citations
Semantic Scholar
Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.
J. Berenson, A. Lichtenstein, L. Porter, M. Dimopoulos +13 more
1998Journal of Clinical Oncology675 citations
Semantic Scholar
Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma.
R. Vescio, G. Schiller, A. Stewart, O. Ballester +17 more
1999Blood156 citations
Semantic Scholar
Prevention of Breast Cancer (Part I): Epidemiology, Risk Factors, and Risk Assessment Tools
M. T. Tria Tirona, R. Sehgal, O. Ballester
2010Cancer Investigation79 citations
Semantic Scholar
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency
O. Ballester, R. Tummala, W. Janssen, K. Fields +9 more
1997Bone Marrow Transplantation77 citations
Semantic Scholar
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.
K. Fields, G. Elfenbein, H. Lazarus, B. W. Cooper +6 more
1995Journal of Clinical Oncology76 citations
Semantic Scholar
Anergy, zinc deficiency, and decreased nucleoside phosphorylase activity in patients with sickle cell anemia.
O. Ballester, A. S. Prasad
1983Annals of Internal Medicine61 citations
Semantic Scholar
Acquired factor VIII deficiency and polyradiculoneuropathy.
Linda L Garland, B. Cadigan, O. Ballester, H. Saba
1991New England Journal of Medicine53 citations
Semantic Scholar
RBC and WBC fatty acid composition following consumption of an omega 3 supplement: Lessons for future clinical trials
Theodore R. Witte, Alexander J. Salazar, O. Ballester, W. Hardman
2010Lipids in Health and Disease40 citations Open access
Semantic Scholar
Cost‐effectiveness of white cell‐reduction filters in treatment of adult acute myelogenous leukemia
Lodovico Balducci, K. Benson, Gary H. Lyman, R. Sanderson +3 more
1993Transfusion40 citations
Semantic Scholar
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
K. Fields, G. Elfenbein, Janelle B. Perkins, J. Hiemenz +5 more
1993Seminars in Oncology38 citations
Semantic Scholar
The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
K. Benson, K. Fields, J. Hiemenz, P. Zorsky +3 more
1993Seminars in Oncology38 citations
Semantic Scholar
Inhibition of Nuclear Factor Kappa B activation in Early-Stage Chronic Lymphocytic Leukemia by Omega-3 Fatty Acids
J. F. Fahrmann, O. Ballester, G. Ballester, Theodore R. Witte +8 more
2013Cancer Investigation31 citations
Semantic Scholar
Impaired IgM antibody responses to an influenza virus vaccine in adults with sickle cell anemia
O. Ballester, J. Abdallah, A. Prasad
1985American journal of hematology/oncology28 citations
Semantic Scholar
Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC‐IE): a novel, intensive induction chemotherapy regimen for patients with high‐risk multiple myeloma
O. Ballester, L. Moscinski, K. Fields, J. Hiemenz +7 more
1997British Journal of Haematology16 citations Open access
Semantic Scholar
Acute lymphocytic leukemia (all) in elderly patients
J. Virgilio, L. Moscinski, O. Ballester, C. Corrado +3 more
1993Hematological Oncology15 citations
Semantic Scholar
Cytogenetic Alterations in Multiple Myeloma: Prognostic Significance and the Choice of Frontline Therapy
F. Stella, E. Pedrazzini, Mara Agazzoni, O. Ballester +1 more
2015Cancer Investigation14 citations Open access
Semantic Scholar
The National Cancer Institute Silicone Implant/Multiple Myeloma Registry.
C. Rabkin, S. Silverman, G. Tricot, Linda L Garland +2 more
1996Current Topics in Microbiology and Immunology14 citations
Semantic Scholar
Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
O. Ballester, D. Agaliotis, J. Hiemenz, W. Janssen +5 more
1996Bone Marrow Transplantation12 citations
Semantic Scholar
Multiple myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk.
Linda L Garland, O. Ballester, F. Vasey, K. Benson +4 more
1996Current Topics in Microbiology and Immunology12 citations
Semantic Scholar
Pure red cell aplasia: treatment with intravenous immunoglobulin concentrate.
O. Ballester, H. Saba, L. Moscinski, Robert K. Nelson +1 more
1992Seminars in hematology (Print)12 citations
Semantic Scholar
Mobilization of peripheral blood stem cells: comparing cyclophosphamide and growth factor based regimens.
W. Janssen, R. Smilee, R. Carter, D. Rahn +6 more
1994Progress in clinical and biological research11 citations
Semantic Scholar
Acute Myelogenous Leukemia in the Elderly
O. Ballester, L. Moscinski, D. Morris, L. Balducci
1992Journal of The American Geriatrics Society11 citations
Semantic Scholar
Frontline Therapy for Multiple Myeloma: A Concise Review of the Evidence Based on Randomized Clinical Trials
S. Yaqub, G. Ballester, O. Ballester
2013Cancer Investigation10 citations
Semantic Scholar
High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion.
K. Fields, G. Elfenbein, J. Perkins, W. Janssen +5 more
1994Seminars in Oncology10 citations
Semantic Scholar
Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma
O. Ballester, T. Fang, A. Raptis, G. Ballester +3 more
2004Bone Marrow Transplantation9 citations Open access
Semantic Scholar
Hematopoietic stem cell transplantation in the elderly.
G. Ballester, M. T. Tria Tirona, O. Ballester
2007Oncology8 citations
Semantic Scholar
Defining the role of novel high-dose chemotherapy regimens for the treatment of high-risk breast cancer.
K. Fields, G. Elfenbein, Janelle B. Perkins, O. Ballester +6 more
1998Seminars in Oncology8 citations
Semantic Scholar
Allogeneic bone marrow transplantation for multiple myeloma.
O. Ballester
1993Seminars in Oncology8 citations
Semantic Scholar
Randomized clinical trials for hematopoietic stem cell transplantation: lessons to be learned from the European experience
S. Kuthiala, G. Lyman, O. Ballester
2006Bone Marrow Transplantation6 citations Open access
Semantic Scholar
Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients
R. Vescio, C.-H. Wu, L. Zheng, D. Sheen +17 more
2000Bone Marrow Transplantation6 citations
Semantic Scholar
High-dose Chemotherapy and the Treatment of Metastatic Breast Cancer: Selecting the Regimen and the Source of Stem Cells.
K. Fields, Agaliotis Dp, W. Janssen, Janelle B. Perkins +4 more
1994Cancer Control: Journal of the Moffitt Cancer Cente4 citations
Semantic Scholar
Blood and Bone Marrow Hematopoietic Stem Cells for Transplantation: A Comparative Review.
William E. Janssen, J. Hiemenz, K. Fields, Zorsky Pe +3 more
1994Cancer Control: Journal of the Moffitt Cancer Cente4 citations
Semantic Scholar
Prevention of Breast Cancer (Part II): Risk Reduction Strategies
M. T. Tria Tirona, R. Sehgal, O. Ballester
2010Cancer Investigation3 citations
Semantic Scholar
Oral Supplementation with Omega3 Fatty Acids Inhibits NFkB Activation In Chronic Lymphocytic Leukemia (CLL) Cells.
O. Ballester, J. F. Fahrmann, Theodore R. Witte, G. Ballester +1 more
20103 citations
Semantic Scholar
Polycythemia as a complication of human immunodeficiency virus infection.
Thomas B. Edwards, R. P. Nelson, O. Ballester, H. Saba +1 more
1993Southern medical journal (Birmingham, Ala. Print)3 citations
Semantic Scholar
Classic Hemophilia in Elderly Patients
O. Ballester, Ting-Yeung Wang, H. Saba, G. Morelli +2 more
1992Journal of The American Geriatrics Society3 citations
Semantic Scholar
Impaired antibody responses to a pneumococcal polysaccharide vaccine in patients with non-Hodgkin's lymphoma in remission
O. Ballester, M. Shurafa, H. Toben, Kapisthalam S. Kumar +1 more
1981Journal of Clinical Immunology3 citations
Semantic Scholar
Regional Transcatheter Therapy of Hepatic Neoplasms
O. Ballester
20122 citations
Semantic Scholar
Effect of haemoglobin and endogenous erythropoietin on hypothalamic‐pituitary thyroidal and gonadal secretion: an analysis of anaemic (high EPO) and polycythaemic (low EPO) patients
G. Ramirez, Polly A. Bittle, Hamid A. A. Rabb, O. Ballester +1 more
1995Clinical Endocrinology2 citations
Semantic Scholar
The Emperor's New Clothes or the Current Practice of Clinical Trials for Multiple Myeloma in the USA
O. Ballester
2008Cancer Investigation1 citations
Semantic Scholar
Up-Front Therapy for Multiple Myeloma: A Survey of Practice Patterns in the USA.
Kavita Natarajan, G. Lyman, O. Ballester
20051 citations
Semantic Scholar
Inhibition of nuclear factor kappa B activation in early stage chronic lymphocytic leukemia by omega 3 fatty acids
J. F. Fahrmann, O. Ballester, G. Ballester, Theodore R. Witte +6 more
20120 citations
Semantic Scholar
Does Upfront Therapy with Fludarabine Increase the Risk of Histological Transformation In Patients with Follicular Lymphoma
S. Yaqub, T. Gress, O. Ballester
20100 citations
Semantic Scholar
Abbreviated, Dose Dense Fludarabine and Rituximab for Elderly Patients with Indolent B Cell Malignancies.
G. Ballester, L. Frazer, M. T. Tria Tirona, O. Ballester
20090 citations
Semantic Scholar
Therapeutic decision making in hematopoietic stem cell transplantation for multiple myeloma
O. Ballester, R. Munker, H. Lazarus, K. Atkinson
20090 citations
Semantic Scholar
Hodgkin's Lymphoma in the Elderly Patient: Impact of Age and Co-Morbidities On Outcomes.
S. Nakkar, Toni O. Pacioles, G. Ballester, M. T. Tria Tirona +1 more
20090 citations
Semantic Scholar
Effects of An Omega 3 Fatty Acid Supplement Consumption On Platelet Aggregation Tests in Patients Low Grade Lymphoproliferative Disorders.
G. Ballester, Alexander J. Salazar, T. Witte, E. Hardman +2 more
20090 citations
Semantic Scholar
Blood Disorders in the Elderly: Acute lymphoblastic leukemia in the elderly patient: diagnosis and therapy
S. Bruno, F. Mazzella, O. Ballester
20070 citations
Semantic Scholar
Therapy-Related Acute Lymphoblastic Leukemia (t-ALL).
C. Escobar, J. Mclarty, O. Ballester
20060 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Fields×12
Invite
K. Fields — researcher profile on SciRah
G. Ballester×9
Invite
G. Ballester — researcher profile on SciRah
G. Elfenbein×8
Invite
G. Elfenbein — researcher profile on SciRah
J. Hiemenz×8
Invite
J. Hiemenz — researcher profile on SciRah

×7

Invite

W. Janssen — researcher profile on SciRah

M. T. Tria Tirona×5

Invite

M. T. Tria Tirona — researcher profile on SciRah

Invite

J. Perkins — researcher profile on SciRah

Invite

H. Saba — researcher profile on SciRah

Theodore R. Witte×4

Invite

Theodore R. Witte — researcher profile on SciRah

Alexander J. Salazar×4

Invite

Alexander J. Salazar — researcher profile on SciRah

Invite

P. Zorsky — researcher profile on SciRah

Linda L Garland×3

Invite

Linda L Garland — researcher profile on SciRah